Share：
Share this content in WeChat
X
[Chinese][PDF]70478
• Experience Exchanges •
Evaluation of Her-2 gene expression in endometrial carcinoma by amide proton transfer weighted and fat quantitative
TIAN Shifeng  LIU Ailian  REN Xue  CHEN Lihua  WANG Nan  LIN Liangjie  WANG Jiazheng  ZHANG Yi  ZHANG Ting 

Cite this article as: Tian SF, Liu AL, Ren X, et al. Evaluation of Her-2 gene expression in endometrial carcinoma by amide proton transfer weighted and fat quantitative[J]. Chin J Magn Reson Imaging, 2021, 12(11): 70-73. DOI:10.12015/issn.1674-8034.2021.11.015.


[Abstract] Objective To explore the value of amide proton transfer weighted (APTw) imaging and fat quantitative measurement (mDIXON-Quant) techniques in evaluating the expression of human epidermal growth factor receptor-2 (Her-2) gene in endometrial carcinoma (EC).Materials and Methods: The data of 26 patients with EC confirmed by operation and pathology were retrospectively analyzed, including 11 cases in Her-2 positive group and 15 cases in Her-2 negative group. 3.0 T MR examination was performed before operation. The scanning sequence included APTw and mDIXON-Quant. After scanning, the APT map of APTw sequence and R2* map, fat fraction (FF) map of mDIXON-Quant sequence were obtained by post-processing. The values of APT, R2* and FF of the two groups were measured by two observers respectively. Intra-class correlation coefficients (ICC) was used to test the consistency of the two observers' measurement results of the parameters of the two groups. The differences of each parameter value of the two groups were compared by using the independent sample t test or Mann Whitney U test. ROC curve was used to evaluate the efficiency of the parameters with statistical difference evaluating the expression of Her-2 gene in EC. Area under the curve (AUC), corresponding cut-off value, sensitivity and specificity were calculated.Results The data measured by two observers were consistent (ICC＞0.75).The values of APT, R2* and FF in the Her-2 positive group were 2.850% (2.300%, 2.900%)、(17.102±2.333) Hz and 1.629%±1.086%, respectively. The above parameters were 2.313%±0.415%、(15.134±1.854) Hz and 1.476%±1.131% respectively in the Her-2 negative group. The APT, R2* values of Her-2 positive group were higher than those in the Her-2 negative group, the difference was statistically significant (P＜0.05). There was no statistically significant difference in FF values between the two groups (P＞0.05). The AUC of APT, R2* values in evaluating the expression of Her-2 gene in EC were 0.755 and 0.739, the cutoff value were 2.475% and 16.503 Hz, the sensitivity were 72.7% and 63.6%, the specificity were 80.0% and 86.7%, respectively.Conclusions APTw and mDIXON-Quant have the potential to evaluate the expression of EC Her-2 gene half quantitatively, and have certain clinical application value.
[Keywords] endometrial carcinoma；human epidermal growth factor receptor-2；magnetic resonance imaging；amide proton transferweighted；fat quantitative；prediction

TIAN Shifeng1, 2   LIU Ailian1, 2*   REN Xue1, 2   CHEN Lihua1, 2   WANG Nan1, 2   LIN Liangjie3   WANG Jiazheng3   ZHANG Yi4   ZHANG Ting1, 2  

1 Department of Radiology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China

2 Dalian Medical Imaging artificial intelligence engineering technology research center, Dalian 116011, China

3 Philips (China) Investment Co., Ltd, Shanghai 200040, China

4 Key Laboratory for Biomedical Engineering of Ministry of Education, Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou 310012, China

Liu AL, E-mail: liuailian@dmu.edu.cn

Conflicts of interest   None.

ACKNOWLEDGMENTS Dalian Horizontal Topic "Application value of compressed sensing in the whole body" (No. 2021-01).
Received  2021-06-17
Accepted  2021-08-27
DOI: 10.12015/issn.1674-8034.2021.11.015
Cite this article as: Tian SF, Liu AL, Ren X, et al. Evaluation of Her-2 gene expression in endometrial carcinoma by amide proton transfer weighted and fat quantitative[J]. Chin J Magn Reson Imaging, 2021, 12(11): 70-73. DOI:10.12015/issn.1674-8034.2021.11.015.

[1]
Diver EJ, Foster R, Rueda BR, et al. The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer[J]. Oncologist, 2015, 20(9): 1058-1068. DOI: 10.1634/theoncologist.2015-0149.
[2]
Buchynska LG, Brieieva OV, Iurchenko NP. Assessment of HER-2/neu, с-MYC and CCNE1 gene copy number variations and protein expression in endometrial carcinomas[J]. Exp Oncol, 2019, 41(2): 138-143. DOI: 10.32471/exp-oncology.2312-8852.vol-41-no-2.12973.
[3]
Laterza MM, Ciaramella V, Facchini BA, et al. Enhanced antitumor effect of trastuzumab and duligotuzumab or ipatasertib combination in HER-2 positive gastric cancer cells[J]. Cancers (Basel), 2021, 13(10): 2339. DOI: 10.3390/cancers13102339.
[4]
Fader AN, Roque DM, Siegel E, et al. Randomized phase II trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-trastuzumab in uterine serous carcinomas that overexpress human epidermal growth factor receptor 2/neu[J]. J Clin Oncol, 2018, 36(20): 2044-2051. DOI: 10.1200/JCO.2017.76.5966.
[5]
Banet N, Shahi M, Batista D, et al. HER-2 amplification in uterine serous carcinoma and serous endometrial intraepithelial carcinoma[J]. Am J Surg Pathol, 2021, 45(5): 708-715. DOI: 10.1097/PAS.0000000000001682.
[6]
Chen Y, Wang XQ, Su T, et al. Feasibility evaluation of amide proton transfer-weighted imaging in the parotid glands: a strategy to recognize artifacts and measure APT value[J]. Quant Imaging Med Surg, 2021, 11(6): 2279-2291. DOI: 10.21037/qims-20-675.
[7]
Jiang YH, Liu YYQ, Gao BB, et al. Acid-base metabolism variants in infarct core and penumbra using amide proton transferweighted imaging in subacute cerebral infarction[J]. Chin J Radiol, 2021, 55(5): 500-506. DOI: 10.3760/cma.j.cn112149-20200513-00682.
[8]
Bainbridge A, Bray TJP, Sengupta R, et al. Practical approaches to bone marrow fat fraction quantification across magnetic resonance imaging platforms[J]. J Magn Reson Imaging, 2020, 52(1): 298-306. DOI: 10.1002/jmri.27039.
[9]
Wu QL, Zhang XQ, Ni HY. The application value of mDIXON-Quant sequence in the quantification of liver and pancreatic irondeposition in blood transfusion-dependent diseases[J]. Chin J Radiol, 2019, 53(6): 470-474. DOI: 10.3760/cma.j.issn.1005?1201.2019.06.006.
[10]
Lee DW, Heo H, Woo DC, et al. Amide proton transfer-weighted 7-t mri contrast of myelination after cuprizone administration[J]. Radiology, 2021, 299(2): 428-434. DOI: 10.1148/radiol.2021203766.
[11]
Mahzouni P, Movahedipour M. An immunohistochemical study of HER2 expression in meningioma and its correlation with tumor grade[J]. Pathol Res Pract, 2012, 208(4): 221-224. DOI: 10.1016/j.prp.2012.01.009.
[12]
Chuang TC, Wu K, Lin YY, et al. Dual down-regulation of EGFR and ErbB2 by berberine contributes to suppression of migration and invasion of human ovarian cancer cells[J]. Environ Toxicol, 2021, 36(5): 737-747. DOI: 10.1002/tox.23076.
[13]
Fang WF, Zhao S, Liang Y, et al. Mutation variants and co-mutations as genomic modifiers of response to afatinib in HER2-mutant lung adenocarcinoma[J]. Oncologist, 2020, 25(3): e545-e554. DOI: 10.1634/theoncologist.2019-0547.
[14]
Arslan M, Karadag D, Kalyoncu S. Conformational changes in a Vernier zone region: Implications for antibody dual specificity[J]. Proteins, 2020, 88(11): 1447-1457. DOI: 10.1002/prot.25964.
[15]
Li BB, Sun HZ, Zhang SY, et al. Amide proton transfer imaging to evaluate the grading of squamous cell carcinoma of the cervix: a comparative study using 18F FDG PET[J]. J Magn Reson Imaging, 2019, 50(1): 261-268. DOI: 10.1002/jmri.26572.
[16]
Meng N, Wang J, Sun J, et al. Using amide proton transfer to identify cervical squamous carcinoma/adenocarcinoma and evaluate its differentiation grade[J]. Magn Reson Imaging, 2019, 61:9-15. DOI: 10.1016/j.mri.2019.05.005.
[17]
Takayama Y, Nishie A, Togao O, et al. Amide proton transfer mr imaging of endometrioid endometrial adenocarcinoma: association with histologic grade[J]. Radiology, 2018, 286(3): 909-917. DOI: 10.1148/radiol.2017170349.
[18]
Li BB, Sun HZ, Zhang SY, et al. The utility of APT and IVIM in the diagnosis and differentiation of squamous cell carcinoma of the cervix: a pilot study[J]. Magn Reson Imaging, 2019, 63:105-113. DOI: 10.1016/j.mri.2019.08.020.
[19]
Meng N, Wang XJ, Sun J, et al. Application of the amide proton transfer-weighted imaging and diffusion kurtosis imaging in the study of cervical cancer[J]. Eur Radiol, 2020, 30(10): 5758-5767. DOI: 10.1007/s00330-020-06884-9.
[20]
Craft ML, Edwards M, Jain TP, et al. R2 and R2* MRI assessment of liver iron content in an undifferentiated diagnostic population with hyperferritinaemia, and impact on clinical decision making[J]. Eur J Radiol, 2021, 135:109473. DOI: 10.1016/j.ejrad.2020.109473.
[21]
Tian SF, Liu AL, Zhu W, et al. Correlation between multi-parameter quantitative measurement of enhanced T2*-weightedAngiography sequence and the expression of proliferating cell nuclear antigen Ki-67 ofEndometrial Carcinoma[J]. Chin J Med Imaging, 2018, 26(11): 865-869. DOI: 10.3969/j.issn.1005-5185.2018.11.017.
[22]
Tian SF, Liu AL, Chen LH, et al. Prediction ofmicrosatellite instability in endometrialcarcinoma by multiple quantitativeparameters of magnetic sensitivesequence[J]. Chin J Magn Reson Imaging, 2020, 11(7): 493-496. DOI: 10.12015/issn.1674-8034.2020.07.003.

PREV The value of whole-lesion histogram analysis of MR images in differentiating uterine cellular leiomyoma from degeneration of uterine leiomyoma
NEXT Orbital and craniocerebral magnetic resonance imaging promotes precise diagnosis and treatment of retinoblastoma: the interpretation of a consensus on imaging examination and diagnosis of retinoblastoma
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn